GME Logo

User login

User menu

GME Meeting Planner

6th Annual Mood Disorders Summit


Our thoughts are with everyone affected by Hurrican Dorian. We are pleased to share that our meeting venue, the Charleston Marriott, is open for business and this meeting will take place as planned.  If you have any questions, please contact us at [email protected] 

This activity is jointly provided by Postgraduate Institute for Medicine and Global Medical Education and in partnership with myCME/Haymarket Medical Education.

Join fellow healthcare professionals and learn from the world’s leading experts at this FREE comprehensive two-day conference, which will explore state of the art diagnostic and therapeutic issues in patients with mood disorders.

Discounted Room Block

GME is pleased to offer discounted room rate of $205.00 / night for the duration of our conference.  To book a room under the block, please click this link or call 1-800-228-9290 and reference GME Mood Disorders Summit. 

This activity is supported by an independent educational grant from Allergan, Sunovion, Neurocrine Biosciences, Takeda and Lundbeck.


Target Audience

This activity is intended for physicians, physician’s assistants, nurse practitioners, pharmacists, psychologists, registered nurses, and other healthcare professionals engaged in the care of patients with mood disorders.


Educational Objectives

After completing this activity, the participant should be better able to:

• Identify reasons for the misdiagnosis of mood disorders.

• Describe role of evolution and inflammation in mood disorders.

• Employ evidence-based treatments for major depression including treatment resistant patients.

• Describe pharmacotherapies for mixed episodes of bipolar disorder and comorbid ADHD.

• Describe pharmacotherapies for depressive episodes of bipolar disorder.

• Describe the prevalence and management of tardive dyskinesia in mood disorders.

• Use strategies to improve adherence, including the role of long acting injectables.

• Utilize strategies to manage side effects of medications in patients.

• Employ evidence-based psychotherapies in patients with mood disorders.


Joint Accreditation Statement  

Jointly%20Accredited%20Provider%20TMIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Medical Education.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.




Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 13 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 13.0 contact hour(s) (1.30 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number –JA4008162-9999-19-883-L01-P

Type of Activity: Knowledge


Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 13 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate. Designated for 4.1 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.


California Board of Registered Nursing

Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 13 contact hours.


AAPA Credit Designation Statement

This activity is designated for 13 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.


Continuing Psychology Education

Postgraduate Institute for Medicine (PIM) is approved by the American Psychological Association to sponsor continuing education for psychologists.  PIM maintains responsibility for this program and its content.

This program offers 13.0 continuing education credits for psychologists.


Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.



Roger S. McIntyre, MD – Consulting Fees Lundbeck, Janssen, Shire, Pfizer, Otsuka, Allergan, Takeda, Neurocrine, Sunovion, Minerva

Sanjay Gupta, MD - Consulting fees Neurocrine; Speakers Bureau-Otsuka, Sunovion, Takeda, Allergan, Neurocrine, Alkermes, Janssen

Prakash Masand, MD – Consulting fees Allergan, Lundbeck, Sunovion, Takeda; Contracted Research Allergan; Speaker’s Bureau Allergan, Lundbeck, Sunovion, Takeda

James Murrough, MD – Consulting fees Otsuka, Clexio Biosciences, FSV&, Boehreinger Ingelheim, Sage Therapeutics, Allergan, Fortress Biotech, Medavante-Prophase

Randolph Nesse, MD - nothing to disclose

Anthony Rostain, MD – Royalties St, Martin’s Press, Routledge/Taylor Francis Group; Consulting fees Takeda/Shire, Arbor, Tris; Speaker’s Bureau Macmillan, National Football League

Thomas L. Schwartz, MD – Royalties Cambridge University Press, Routledge Press

Manpreet K. Singh, MD – Consulting fees Sunovion, Google X, Limbix; Research Support: NIMH, PCori, Allergan, Johnson and Johnson, Stanford Maternal Health Research Institute

Leonardo Tondo, MD nothing to disclose


Planners and Managers

The PIM planners and managers have nothing to disclose. The GME planners and managers have nothing to disclose.


Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.



Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.


Request for Credit

A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within 4 weeks.

For Pharmacists: Upon receipt of the completed activity evaluation form, you will receive an email from [email protected] within 3 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service.

Program Agenda

Day 1 - Friday, September 20, 2019

7:30 - 8:15 AM: Registration and Breakfast

8:15 - 8:30 AM: Opening Remarks by Chair

8:30 - 9:30 AM: Keynote Address: "Mood Disorders in DSM-5: An Evolutionary Perspective" Randolph Nesse MD (Arizona State University)

9:30 - 10:30 AM: "Inflammation and "Metaboptosis": Implications for Novel Treatments in Mood Disorders" Roger McIntyre, MD (University of Toronto) 

10:30 - 11:30 AM: Debate: "Pharmacogenetic Testing in Psychiatry: Useless or Useful?" Roger McIntyre MD/ Thomas Schwartz MD

11:30 - 11:45 AM: Break

11:45 AM - 12:45 PM:  Hot Topics (Six clinically relevant and topical issues for 8 minutes each)

12:45 - 2:00 PM: Lunch

2:00 - 3:00 PM: "Advances in the Management of Bipolar Depression" Thomas Schwartz MD (SUNY Syracuse)

3:00 - 3:15 PM: Break

3:15 - 4:15 PM:  Non-CME Product Theater

4:15 -5:15 PM:  Break

4:30 - 5:30 PM: "Mixed Symptoms in Major Depression?" Leonardo Tondo, MD (Harvard)

5:30 - 6:30 PM: "Pediatric Mood Disorders: Challenges and Opportunities" Manpreet Singh MD (Stanford)

6:30 -7:30 PM: Poster Reception


Day 2 - Saturday, September 21, 2019

7:30 - 8:30 AM: Breakfast

8:30 - 9:30 AM: Debate: "Standard Antidepressants Should Not Be First Line Treatment in Major Depression with Mixed Specifier" James Murrough MD / Sanjay Gupta MD

9:30 - 10:30 AM: "Comorbidity of Mood Disorders and ADHD Across the Life Cycle" Antony Rostain, MD (Univ of Penn)

10:30 - 11:30 AM: "Managing Treatment Resistant Major Depression" Prakash Masand, MD (Duke-NUS)

11:30 -11:45 AM: Break

11:45 AM - 12:45 PM: Hot Topics (Six clinically relevant and topical issues for 8 minutes each)

12:45 - 2:00 PM:  Lunch

2:00 - 3:00 PM: "Mood Disorders and Tardive Dyskinesia" Sanjay Gupta, MD (SUNY Upstate)

3:00-3:15 PM: Break

3:15 - 4:15 PM:  Non-CME Product Theater

4:15 - 5.15 PM:  Break

4:30 - 5:30 PM: "What is New About Newer Antidepressants?" James Murrough, MD (Mt Sinai New York)

*subject to change 

Faculty Members Scheduled to Attend

Sanjay Gupta, MD
Clinical Professor of Psychiatry
SUNY Buffalo
Prakash Masand, MD
SVP and Chief Medical Officer, Neuroscience, CCO
Adjunct Professor, Duke-National University of Singapore Medical School
James Murrough, MD
Associate Professor of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai
Randolph Nesse, MD
ASU Foundation Professor at Arizona State University
Anthony Rostain, MD
Professor of Psychiatry and Pediatrics, Perelman School of Medicine
Thomas L. Schwartz, MD
Professor of Psychiatry and Director of Adult Psychiatric Clinical Services, SUNY Upstate Medical University
Manpreet K. Singh, MD
Associate Professor of Psychiatry and Behavioral Sciences
Stanford University
Leonardo Tondo, MD
Research Associate, Harvard Medical School

Location and Date

Charleston Marriott
Crystal ABCD
170 Lockwood Blvd.
Charleston, SC

GME is not taking registrations for this meeting. Please see information on registration in the "Program Overview" section.

Join GME for Free!

Become a GME subscriber and gain full access to our extensive library of 700+ psychiatric medical education videos,
free CME webcasts, latest research updates, and more. To sample our content, watch the featured videos below.
Join Today!

GME Activities Calendar

JUNE 27, 2021
Psychiatry Update 2021 for APPs
JUNE 29, 2021
Challenges in Treating Tardive Dyskinesia
AUGUST 17, 2021
Innovations in Management of Bipolar Depression
SEPTEMBER 10-11, 2021
8th Annual Mood Disorders Summit
OCTOBER 02, 2021
Treating Schizophrenia: Can We Do Better?
OCTOBER 09, 2021
Psychiatry Update 2021
Live Virtual Webcast
OCTOBER 23, 2021
Psychiatry Update 2021
Live Virtual Webcast
DECEMBER 10-11, 2021
7th Annual Psychopharmacology Update
MARCH 24-26, 2022
Inaugural Psychiatry Summit 2022

To contact GME, email us at [email protected]

GME does not provide medical advice. The website and articles are intended for informational purposes only. They are not a substitute for professional medical advice, diagnosis or treatment. Never ignore professional medical advice in seeking treatment because of something you have read on the GME Website. If you think you may have a medical emergency, immediately call your doctor or dial 911.

Log In


Join GME For Free

Become a GME subscriber and gain full access to our extensive library of 700+ psychiatric medical education videos, free CME webcasts, latest research updates, and more. To sample our content, watch the featured videos below.
Join Today!